Home Investment

Investment

UK doctors told to ignore consumer genetic tests

Royal College of General Practitioners guidance places significant doubt on consumer genetic testing. Consumer interest in genetic testing has grown in popularity in recent years,...

The Longevity Week: Addressing global Longevity

A packed week of multidisciplinary events with a global focus on the Longevity challenge. One year ago, the first Longevity Forum event was held in...

Human Longevity, Inc: $30m injection. Challenges?

Trouble in paradise? Or extra funding for new goals in precision health analytics? The abrupt press announcement on the Human Longevity, Inc. website was one...

Ervaxx exits stealth mode with $17.5 million

UK start-up Ervaxx targets 'dark matter' genes to develop cell therapies. After two years in stealth mode, the new UK-based start-up Ervaxx has stepped out of...

AI in peptide discovery: A growing trend

Israeli start-up bags $5 million Series A to drive development of new AI models. Like London buses, we write about one company using artificial intelligence...

Meet the Start-up: Zone V: Currently fundraising

Accessible technology firm, already partnering with Samsung, raising funds to make smartphones easier to use for older users. We are pleased to announce the start...

60 new Biotech and Agetech start-ups to join showcase

Applications open for the Longevity Leaders World Congress start-up showcase. The Longevity sector is in part characterised by the emergence of two exciting classes of...

Agetech market slated to double from $1 to $2 trillion

We’re all interested in qualifying how big the Longevity sector will be and the good news is that Dominic Endicott has been hitting the...

Zealand Pharma bets bigger on peptides

The Copenhagen biotech's acquisition of Encycle Therapeutics demonstrates growing market interest in peptide-based drugs. Zealand Pharma, a Copenhagen-based biotech company focused on the development of...

The Longevity biotech industry is hitting its stride

An exclusive with AgeX Therapeutics CEO Dr Michael West looks at the puzzle of aging. AgeX Therapeutics is an American biotechnology developing novel therapeutics that...

ADVERT

ADVERT

Latest articles

UK doctors told to ignore consumer genetic tests

Royal College of General Practitioners guidance places significant doubt on consumer genetic testing. Consumer interest in genetic testing has grown in popularity in recent years,...

New study shows rapamycin slows Alzheimer’s

A new study from UT Health San Antonio suggests the drug rapamycin may be able to slow the rate of brain-related blood flow decreases. The...

Meet the Startup: Kintell’s take on Alexa Skills

New IoT device focuses on prolonging independence for the broader aging population. While there are many technologies out there designed to help older people who...

The Longevity Week: Addressing global Longevity

A packed week of multidisciplinary events with a global focus on the Longevity challenge. One year ago, the first Longevity Forum event was held in...

Sign-up for daily news on the research, investments and technologies driving the Longevity market.

Sign-up for daily news on the research, investments and technologies driving the Longevity market.